Alnylam Pharmaceuticals
ALNY
#624
Rank
NZ$56.49 B
Marketcap
$436.40
Share price
-0.16%
Change (1 day)
74.30%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company